Analiza przydatności prognostycznej polimorfizmów 420C/T, 750A/T oraz -857C/T w obrębie genu TNF-α w populacji polskiej u pacjentów z chorobą Leśniowskiego-Crohna

Introduction
Inflammatory bowel diseases (IBD) most commonly occur in two different forms: as ulcerative colitis (UC) and as Crohn’s disease. In 10-15% of cases qualification to either of these disease categories is impossible and in this case indeterminate colitis (IC) is diagnosed.
Crohn’s disease is becoming a more frequent cause of hospitalizations of Polish patients on hospital words. It is characterized by an inflammatory process in the wall of the GI tract, loose stools, ulcerations and in advanced stages of the disease also by fistulas and abscesses. Symptoms of the disease can occur in the whole length of the GI tract, although they occur most commonly in the terminal ileum and colon. Besides the symptoms from the gastrointestinal tract, extra-intestinal symptoms also occur, for example: iritis, primary sclerosing cholangitis, arthropathies, skin changes as well as stomatitis aphthosa. The cause of the disease to this day remains unknown, although more and more evidence points to the fact that environmental factors (smoking, diet, etc.) and genetic factors (studies of twins and patient family members) play a large role in the pathogenesis of Crohn’s disease. These factors cause imbalances in the body’s immune system initiating a cascade of immunological reactions which are seen as inflammatory changes in the wall of the gastrointestinal tract.
Currently it is believed that Crohn’s disease is a multifactorial and a polygenic disease. Genes CARD15/NOD2, DLG5, OCTN1, OCTN2 as well as the TNF-α gene are suspected to be involved in the basis of Crohn’s disease. The TNF-α (tumor necro-sis factor a) gene is one of the key factors suspected to be involved in the pathogenesis of Crohn’s disease [1-7]. This key pro-inflammatory cytokine takes part in many bodily functions including the metabolism of lipids, coagulation, insulin resistance, acute phase reactions as well as endothelial functions. Many studies have been done [8-11], as a result of which the TNF-α gene was localized on chromosome 6p21.3. It was found that interactions of TNF-α with TNF receptor play a key role not only in the immunological response but also in the process of programmed cell death, or apoptosis, proliferation of cells and cell differentiation [12-14].
Many polymorphisms of the SNP type are localized in the area of the TNF-α gene as well as in its promoter region. It was found that changes of the SNP type localized in the promoter region can influence the level of expression of the TNF-α gene as well as taking part in the basis of many diseases. For example, the nucleotides localized in positions -238A/G and -308A/G are believed to take part in the pathogenesis of asthma, psoriasis and rheumatoid arthritis [15-18].
This study was undertaken to investigate whether there are any significant SNP changes in the area of the TNF-α gene that can influence the future diagnostics of Crohn’s disease and susceptibility to biological treatment.

Material and methods
In the present work three polymorphisms were chosen for analysis: two are located in the vicinity of the TNF-α gene (420C/T and 750A/T), and one in the promoter region of the gene (-857C/T). These are polymorphisms not frequently analyzed in epidemio-logical studies, and when they were, they showed very little differences. Because it is sometimes observed that polymorphisms that occur frequently in one population do not show any changes in another, we decided to check whether there is any significant difference in the area of the TNF-α gene in Polish patients with CD. The objective of the work was to specify whether these particular polymorphisms show variability in a Polish population of patients with Crohn’s disease.
Studies were conducted on the DNA isolated from systemic blood of 96 patients from the Department of Gastroenterology, Human Nutrition and Internal Diseases of Poznan University of Medical Scienes, Poland. Patients were qualified for the studies on the basis of clinical and radiological tests as well as histopathological results. Blood samples were collected for EDTA and then isolated by a standard GTC method [19]. For the analysis three polymorphisms of the SNP type were chosen: 420C/T, 750A/T, -857C/T. Sequential analyses were conducted for eachof the polymorphisms using a real-time sequencing method, called pyro-sequencing. Specially designed starters were used: two for each of the standard polymerase chain reactions (PCR) and one sequential starter (labelled with biotin) (Table I).
The project was accepted by the ethics committee of the University School of Medical Sciences in Poznan.

Results
While in the NCBI database 420C/T, 750A/T and -857C/T polymorphisms in the TNF-α gene region show very little polymorphism, in the population of Polish patients with Crohn’s disease no differences were observed in these genome locations. Polymorphism 420C/T in all the cases analyzed showed CC variant (Figure 1), in 750A/T variant AA was the only one present (Figure 2), and for polymorphism -857C/T only variant CC was shown (Figure 3).

Discussion
The TNF-α gene is thought to be one of the key factors responsible for Crohn’s disease conditioning. In many other research projects investigators have shown the major role of different polymorphisms in the area of the TNF-α gene that can play a major role in the pathogenesis of the disease. Because sometimes it can be observed that among different populations the frequency of specific alleles or genotypes varies, we decided to check whether such differences can be observed in the Polish population in a group of Crohn’s patients. In the NCBI database polymorphisms 420C/T, 750A/T and -857C/T show slight diversity (among others studied were African, Caucasian and Hispanic populations). Conducted studies showed that in the Polish population, these polymorphisms were not observed in any of the 96 patients. It did not escape our attention that the group of patients was quite small, but due to financial restrictions and no significant results in the first part of the studies we decided to finish with the group of 96 individuals.
According to this study we expect that there are other genetic factors in the Polish population which play a key role in Crohn’s disease conditioning.

Conclusions
Although the TNF-α gene is expected to play one of the major roles in the background of Crohn’s disease, no differentiation was observed in the Polish population. Because of this, it cannot be used for prognostics in the Polish population.

Acknowledgments
This study was supported by university grants from Karol Marcinkowski University School of Medical Sciences in Poznan.

References
1. Ferguson LR, Huebner C, Petermann I, et al. Single nucleotide polymorphism in the tumor necrosis factor-alpha gene affects inflammatory bowel diseases risk. World J Gastroenterol 2008; 14: 4652-61.
2. Silbermintz A, Levine J, Weinstein T, Silver J. Polymorphisms in the tumor necrosis factor/lipopolysaccharides pathway in Crohn disease in the Jewish Ashkenazi population. J Pediatr Gastroenterol Nutr 2008; 46: 546-50.
3. Hong J, Leung E, Fraser AG, et al. IL4, IL10, IL16, and TNF polymorphisms in New Zealand Caucasian Crohn's disease patients. Int J Colorectal Dis 2008; 23: 335-7.
4. Cucchiara S, Latiano A, Palmieri O, et al. Polymorphisms of tumor necrosis factor-alpha but not MDR1 influence response to medical therapy in pediatric-onset inflammatory bowel disease. Italian Society of Pediatric Gastroenterology and Nutrition. J Pediatr Gastroenterol Nutr 2007; 44: 171-9.
5. Fidder HH, Heijmans R, Chowers Y, et al. TNF-857 polymorphism in Israeli Jewish patients with inflammatory bowel disease. Int J Immunogenet 2006; 33: 81-5.
6. Tremelling M, Waller S, Bredin F, Greenfield S, Parkes M. Genetic variants in TNF-αlpha but not DLG5 are associated with inflammatory bowel disease in a large United Kingdom cohort. Inflamm Bowel Dis 2006; 12: 178-84.
7. Zipperlen K, Peddle L, Melay B, et al. Association of TNF-αlpha polymorphisms in Crohn disease. Hum Immunol 2005; 66: 56-9.
8. Hampe J, Schreiber S, Shaw SH, et al. A genomwide analysis provides evidence for novel linkages in inflammatory bowel disease in a large European cohort. Am J Hum Genet 1999; 64: 808-16.
9. Rioux JD, Silverberg MS, Daly MJ, et al. Genomwide search in Canadian families with inflammatory bowel disease reveals two novel susceptibility loci. Am J Hum Genet 2000; 66: 1863-70.
10. Dechairo B, Dimon C, van Heel D, et al. Replication and extension studies of inflammatory bowel disease susceptibility regions confirm linkage to chromosome 6p (IBD3). Eur J Hum Genet 2001; 9: 627-33.
11. Fisher SA, Hampe J, Macpherson AJ, et al. Sex stratification of an inflammatory bowel disease genome search shows male-specific linkage to the HLA region of chromosome 6. Eur J Hum Genet 2002; 10: 259-65.
12. Old LJ. Tumor necrosis factor (TNF). Science 1985; 230: 630-2.
13. Locksley RM, Killeen N, Lenardo MJ. The TNF and TNF receptor superfamilies: integrating mammalian biology. Cell 2001; 104: 487-501.
14. Gaur U, Aggarwal BB. Regulation of proliferation, survival and apoptosis by members of TNF superfamily. Biochem Pharmacol 2003; 66: 1403-8.
15. Moffatt MF, Cookson WO. Tumor necrosis factor haplotypes and asthma. Hum Mol Genet 1997; 6: 551-4.
16. Witte JS, Palmer LJ, O’Connor RD, et al. Relation between tumor necrosis factor polymorphism TNFαlpha-308 and risk of asthma. Eur J Hum Genet 2002; 10: 82-5.
17. Balding J, Kane D, Livingstone W, et al. Cytokine gene polymorphism: association with psoriatic arthritis suscep-tibility and severity. Arthritis Rheum 2003; 48: 1408-13.
18. Mulcahy B, Waldron-LynchF, McDermott MF, et al. Genetic variability in the tumor necrosis factor-lymphotoxin region influences susceptibility to rheumatoid arthritis. Am J Hum Genet 1996; 59: 676-83.
19. Analiza DNA - teoria i praktyka. Ryszard Słomski (red.). Wydawnictwo Uniwersytetu Przyrodniczego, Poznań 2008.